"Designing Growth Strategies is in our DNA"
Tissue diagnostics is widely used in the medical field to analyze a tissue sample for diagnosis of cancer and other disorders. For instance, hematoxylin and eosin stain (H&E), a technology of tissue diagnostics, is often considered as the gold standard by the pathologist for the diagnosis of suspected cancer. Diagnosis and monitoring of various types of cancer are often the most common application of tissue diagnostics, but other types of diseases can also be diagnosed. Tissue diagnostics also leads to the prospect of personalized medicine for various treatment options of cancers.
Tissue diagnostics thus aid in the development of targeted therapies which lead to the prospect of better patient outcomes and also in the prevention of further relapses of the diseases. According to the American Cancer Society (ACS), melanoma or skin of cancer is the most common type of cancer occurring in the U.S., and it is estimated that in 2018, approximately 91,270 new cases of melanomas will occur, comprising of 55,150 in men and 36,120 in women.
To gain extensive insights into the market, Request for Customization
The global tissue diagnostics market is anticipated to grow owing to a number of factors such as the increasing prevalence of various types of cancers, rising demand for preventive care, propelling opportunities in digital pathology, raising awareness campaigns for cancer, advancements in technologies for tissue diagnostics, and efficiency in the diagnosis & monitoring of diseases.
However, factors such as high costs of diagnostic procedures and a dearth of skilled and professional labors associated with tissue diagnostics are responsible for hindering the global tissue diagnostic market growth during the forecast period.
Some of the key players present in the global tissue diagnostics market are Abbott, F. Hoffmann-La Roche Ltd, GE Healthcare, Agilent Technologies, Inc., Danaher, Merck Sharp & Dohme Corp., Sakura Finetek Japan Co., Ltd, Thermo Fisher Scientific Inc., BioGenex, Metropolis Healthcare Limited, and others.
· In-situ hybridization
· Digital Pathology
· Primary & Special Staining
· Prostate Cancer
· Lung Cancer
· Breast Cancer
· Skin Cancer
By End User
· Hospitals & Clinics
· Diagnostics centers
· Contract research organization & research laboratories
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
Among the segmentation of tissue diagnostics market, cancer in the diseased segment accounts for the highest share in the global market owing to the increasing number of cancer cases, smoking habits, high alcohol consumption rates, and genetic variations. These factors are responsible for propelling the cancer segment in the forecast period as well and contribute to the global growth of the tissue diagnostics market.
Geographically, the global tissue diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the tissue diagnostics market owing to factors such as the increasing prevalence of skin & breast cancers, advancing diagnostics & treatment options for cancers, established healthcare system, high healthcare expenditure, increasing investment in tissue diagnostics and rising demand for preventive medical care. Asia Pacific is anticipated to register a higher CAGR owing to increasing incidences & awareness of cancer, development of advanced technologies, large patient population, rising disposable incomes, greater awareness & demand for advanced diagnostic procedures and developing healthcare systems.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry